Exact Sciences Corporation

Direct answer

Exact Sciences Corporation is publicly traded on NASDAQ under the ticker EXAS.

Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the...

Can you invest in Exact Sciences Corporation?

Yes. Exact Sciences Corporation trades publicly on NASDAQ as EXAS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Exact Sciences Corporation

Detailed equity research is provided by MarketSnap.